Earnings
GLMD
4.170
+10.61%
0.400
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2019-12-31
0.00
0.00
--
--
4.20M
18.18M
--
--
--
22.38M
--
-22.38M
1.95M
--
-33.00K
1.95M
-20.46M
0.00
-20.46M
--
-20.46M
-20.46M
--
--
-0.97
FY 2018-12-31
2.04M
2.04M
--
--
4.44M
8.31M
--
--
--
12.75M
--
-10.71M
976.00K
--
-42.00K
976.00K
-9.78M
75.00K
-9.86M
--
-9.86M
-9.86M
--
--
-0.54
FY 2017-12-31
1.08M
1.08M
--
--
3.80M
9.65M
--
--
--
13.45M
--
-12.36M
65.00K
--
--
65.00K
-12.30M
0.00
-12.30M
--
-12.30M
-12.30M
--
--
-0.98
FY 2016-12-31
467.00K
467.00K
--
--
3.08M
14.27M
--
--
--
17.35M
--
-16.88M
35.00K
--
--
35.00K
-16.85M
106.00K
-16.95M
--
-16.95M
-16.95M
--
--
-1.49
FY 2015-12-31
0.00
0.00
--
--
3.25M
7.63M
--
--
0.00
10.88M
--
-10.88M
253.00K
--
--
253.00K
-10.62M
0.00
-10.62M
--
-10.62M
-10.62M
--
--
-0.96

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out GLMD latest quarterly and annual financial reports. There are also past financial reports for you to reference. You can analyze Galmed Pharma recent business situations from balance sheets, income statements, cash flow statements and other tables. This information may help you make smarter investment decisions.